Page last updated: 2024-10-20

thiamine and Supranuclear Palsy, Progressive

thiamine has been researched along with Supranuclear Palsy, Progressive in 1 studies

thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.

Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)

Research Excerpts

ExcerptRelevanceReference
"Progressive supranuclear palsy (PSP) may be a risk factor for thiamine deficiency."3.88Progressive supranuclear palsy responding to intravenous thiamine: superimposed Wernicke's encephalopathy? ( Joshi, H; Patel, J; Prakash, S, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prakash, S1
Joshi, H1
Patel, J1

Other Studies

1 other study available for thiamine and Supranuclear Palsy, Progressive

ArticleYear
Progressive supranuclear palsy responding to intravenous thiamine: superimposed Wernicke's encephalopathy?
    BMJ case reports, 2018, Aug-20, Volume: 2018

    Topics: Administration, Intravenous; Female; Humans; Middle Aged; Supranuclear Palsy, Progressive; Thiamine;

2018